Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Innate Pharma (Nasdaq: IPHA) Receives FDA Clearance to Initiate Phase 3 TELLOMAK 3 Trial

Innate Pharma SA (NASDAQ:IPHA) announced that the U.S. Food and Drug Administration (FDA) has completed its review of the confirmatory Phase 3 protocol for lacutamab in cutaneous T-cell lymphomas (CTCL). The FDA had no further comments, allowing the trial to proceed.

Team Kalkine | 10 November 2025

Viomi (NASDAQ: VIOT) Delivers Record-High Revenue on Home Water Solutions Focus

Viomi Technology Co., Ltd. (NASDAQ:VIOT), a technology company specializing in home water solutions in China, announced its unaudited financial results for the six months ended June 30, 2025.

Team Kalkine | 10 November 2025

Kyivstar (NASDAQ:KYIV) Q3 Revenue Hits USD 297Mn with Digital Revenue Surging 531%

Kyivstar Group Ltd. (NASDAQ:KYIV), Ukraine’s leading digital operator, released selected unaudited financial and operational results for the third quarter ending September 30, 2025. Total revenue climbed 20.9% YoY to UAH 12.3 bn (USD 297 mn), reflecting the Group’s pricing policies and growth in consumer …

Team Kalkine | 10 November 2025

e.l.f. Beauty (NYSE:ELF) Expands Reach with ULTA Beauty Launch in Mexico

e.l.f. Beauty (NYSE:ELF)has officially launched its products at ULTA Beauty locations throughout Mexico, following the brand’s initial market introduction in 2024. The launch represents a continuation of the partnership between e.l.f. and ULTA Beauty, offering customers nationwide access to e.l.f. Cosmetics and e.l.f. SKIN …

Team Kalkine | 10 November 2025

Organon (NYSE:OGN) Reports Pediatric Trial Data Showing VTAMA® Improvements in Atopic Dermatitis

Organon (NYSE:OGN)reported findings from a sub-analysis of pooled data from the Phase 3 ADORING 1 and ADORING 2 trials at the 2025 American College of Allergy, Asthma & Immunology Annual Scientific Meeting. The analysis assessed VTAMA® (tapinarof) cream, 1%, in children aged 2-17 with …

Team Kalkine | 10 November 2025

Merck (NYSE:MRK) Enlicitide Shows 59% LDL-C Reduction in Phase 3 HeFH Trial

Merck (NYSE:MRK), known as MSD outside the U.S. and Canada, released results from the pivotal Phase 3 CORALreef HeFH trial at the American Heart Association Scientific Sessions 2025. The study assessed enlicitide decanoate, an investigational once-daily oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, …

Team Kalkine | 10 November 2025

Edwards Lifesciences (NYSE:EW) Sponsors AHA Heart Valve Initiative to Improve Patient Care

Edwards Lifesciences (NYSE:EW)has announced its founding sponsorship of the American Heart Association’s Heart Valve Initiative, a nationwide effort to enhance care and outcomes for approximately 28 million people worldwide living with heart valve disease. In the U.S., valve disease contributes to over 60,000 deaths …

Team Kalkine | 10 November 2025

VEON Ltd. (NASDAQ:VEON) Raises 2025 Outlook as Digital Revenue Jumps 63%

VEON Ltd. (NASDAQ:VEON)reported a 7.5% year-on-year rise in revenue to USD 1,115 mn for the third quarter ended September 30, 2025. EBITDA grew 19.7% YoY to USD 524 mn, supported by telecom and infrastructure operations along with higher digital contributions. The EBITDA margin expanded …

Team Kalkine | 10 November 2025

Leishen Energy (NASDAQ:LSE) Debuts at ADIPEC 2025, Announces Expansion Across Middle East and Global Markets

Leishen Energy (NASDAQ:LSE)made its debut at the Abu Dhabi International Petroleum Exhibition & Conference, held from November 3–6, 2025. The company used the event, one of the global energy industry’s leading exhibitions, to highlight its technological capabilities and announce strategic initiatives supporting deeper engagement …

Team Kalkine | 10 November 2025

Wynn Resorts (NASDAQ:WYNN) and Marjan Announce Second Al Marjan Island Project with Aman Group

Wynn Resorts, Limited (NASDAQ:WYNN)and Marjan LLC, co-developers of Wynn Al Marjan Island, currently under construction in Ras Al Khaimah, United Arab Emirates, announced their second joint development on Al Marjan Island — Janu Al Marjan Island.

Team Kalkine | 10 November 2025
Support

Hi! How can we help you today?

Loading…